Nods. I’d be curious to know your thoughts (or any others with insight) on the extent that older MSB studies have been updated recently. In March to June this year, 27 MSB studies have updates on clinicaltrials.gov. It seemed odd to me, but I haven’t followed clinicaltrials.gov extremely closely before.
Would it be normal to do a big clean up and compilation of old trial data from other trials when analysing or submitting to FDA a big phase III study? Could it be a sign they are working on more post hoc analysis? Or, could something else be going on?
https://clinicaltrials.gov/ct2/results?term=Mesoblast&lupd_s=01%2F01%2F2020&lupd_e=06%2F30%2F2020&draw=1&rank=26&view=record#rowId25
Analysis of the EAP, page-619
-
- There are more pages in this discussion • 452 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |